| Size | Price | Stock | Qty |
|---|---|---|---|
| 1g |
|
||
| Other Sizes |
| Toxicity/Toxicokinetics |
Interactions
Long-term administration of carbon tetrachloride to rats can induce liver cirrhosis and increase albumin synthesis, but concurrent administration of carbon tetrachloride and L-azacyclobutane-2-carboxylic acid can reduce albumin synthesis and restore serum albumin levels to normal. L-azacyclobutane-2-carboxylic acid can significantly inhibit nitrate reductase activity induced by nitrate in radish and cauliflower leaf tissues with low L-proline content. Simultaneous injection of L-proline can reverse this inhibitory effect. |
|---|---|
| Additional Infomation |
(S)-Azacyclobutane-2-carboxylic acid is the (S)-enantiomer of azacyclobutane-2-carboxylic acid, and also the enantiomer of (R)-azacyclobutane-2-carboxylic acid. It has been reported that (S)-azacyclobutane-2-carboxylic acid exists in lily of the valley (Convallaria majalis), Clavulinopsis helvola, and other organisms with relevant data. See also: beet (partial). Mechanism of Action: Allyl glycine (0.1 mmol) inhibited the uptake of 0.1 μmol of 4,5-(3)H-labeled L-leucine (1 CUI/mmol) and U-(3)H-labeled L-proline (266 MCI/mmol) in rat brain slices. Leucine uptake was not linear with time; L-azacyclobutane-2-carboxylic acid also inhibited proline uptake. L-azacyclobutane-2-carboxylic acid effectively induced amnesia in a single avoidance conditioned reflex test in 2-day-old chicks and prevented mechanoinduced diffusion inhibition in the retinas isolated from 2-3-week-old chicks. In various protein synthesis systems, L-azacyclobutane-2-carboxylic acid can replace L-proline incorporation into proteins. Adding L-azacyclobutane-2-carboxylic acid to the culture medium of fetal rat skulls reduced intracellular free proline content by 40-70% and decreased the rate of proline incorporation into proteins and collagen by 40-70%. Changes in intracellular proline concentration (whether through alteration of extracellular proline concentration or inhibition of proline entry into the intracellular pool) may contribute to the regulation of collagen synthesis. Proline permease in Pseudomonas aeruginosa follows saturation kinetics and is specific for L-proline. L-azacyclobutane-2-carboxylic acid competitively inhibits proline uptake. It can also exchange with a pre-established intracellular pool of labeled proline.
Odontoblasts from 16-day-old mouse embryos treated with L-2-azacyclobutanecarboxylic acid (50, 100, and 200 γ) for 4 days were in late mitosis but unpolarized and did not secrete picric acid-furossing (collagen)-positive material. Odontoblasts from 18-day-old embryos treated with L-2-azacyclobutanecarboxylic acid did not contain picric acid-furossing or striated collagen fibers; pre-odontoblasts were in late mitosis but unpolarized. |
| Molecular Formula |
C₄H₇NO₂
|
|---|---|
| Molecular Weight |
101.10
|
| Exact Mass |
101.047
|
| CAS # |
2133-34-8
|
| PubChem CID |
16486
|
| Appearance |
White to off-white solid powder
|
| Density |
1.3±0.1 g/cm3
|
| Boiling Point |
242.0±33.0 °C at 760 mmHg
|
| Melting Point |
206-207 ºC
|
| Flash Point |
100.1±25.4 °C
|
| Vapour Pressure |
0.0±1.0 mmHg at 25°C
|
| Index of Refraction |
1.499
|
| LogP |
-0.83
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
1
|
| Heavy Atom Count |
7
|
| Complexity |
91.7
|
| Defined Atom Stereocenter Count |
1
|
| SMILES |
C1CN[C@@H]1C(=O)O
|
| InChi Key |
IADUEWIQBXOCDZ-VKHMYHEASA-N
|
| InChi Code |
InChI=1S/C4H7NO2/c6-4(7)3-1-2-5-3/h3,5H,1-2H2,(H,6,7)/t3-/m0/s1
|
| Chemical Name |
(2S)-azetidine-2-carboxylic acid
|
| Synonyms |
LAzetidine2carboxylic acid; L Azetidine 2 carboxylic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: (1). This product requires protection from light (avoid light exposure) during transportation and storage. (2). Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ~100 mg/mL (~989.12 mM)
DMSO :< 1 mg/mL |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (989.12 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 9.8912 mL | 49.4560 mL | 98.9120 mL | |
| 5 mM | 1.9782 mL | 9.8912 mL | 19.7824 mL | |
| 10 mM | 0.9891 mL | 4.9456 mL | 9.8912 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.